Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism

NCT01280448 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.

NCT NCT01280448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01280448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism
Lead sponsor
Taipei Medical University WanFang Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
September 30, 2013
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer